Evidence map›Paper›PMID 25073422›Full record

ArticleProtein & cell2014

Mitochondria-mediated apoptosis in mammals.

Shunbin Xiong, Tianyang Mu, Guowen Wang, Xuejun Jiang

Open access · diamondAbstract read
In one paragraph

Article in Protein & cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 182 papers.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 394 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Shunbin XiongDepartment of Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, 77030, USA.
Tianyang Mu
Guowen Wang
Xuejun Jiang
Dalian Medical University · CNMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · USTianjin Medical University Cancer Institute and Hospital · CN

Funding

Molecular Regulation of Apoptosome ActivityR01CA113890 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JIANG, XUEJUN · 2006 to 2010
$1.4M
NCI NIH HHS R01 CA113890
6 · The paper itself

Abstract

The mitochondria-mediated caspase activation pathway is a major apoptotic pathway characterized by mitochondrial outer membrane permeabilization (MOMP) and subsequent release of cytochrome c into the cytoplasm to activate caspases. MOMP is regulated by the Bcl-2 family of proteins. This pathway plays important roles not only in normal development, maintenance of tissue homeostasis and the regulation of immune system, but also in human diseases such as immune disorders, neurodegeneration and cancer. In the past decades the molecular basis of this pathway and the regulatory mechanism have been comprehensively studied, yet a great deal of new evidence indicates that cytochrome c release from mitochondria does not always lead to irreversible cell death, and that caspase activation can also have non-death functions. Thus, many unsolved questions and new challenges are still remaining. Furthermore, the dysfunction of this pathway involved in cancer development is obvious, and targeting the pathway as a therapeutic strategy has been extensively explored, but the efficacy of the targeted therapies is still under development. In this review we will discuss the mitochondria-mediated apoptosis pathway and its physiological roles and therapeutic implications.

Indexed as

ApoptosisAnimalsAntineoplastic AgentsCaspasesCytochromes cHumansInhibitor of Apoptosis ProteinsMembrane Potential, MitochondrialMitochondriaNeoplasmsProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsCaspasesCytochromes cInhibitor of Apoptosis ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID25073422
PMCPMC4180462
OpenAlexW2082540550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.